Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.837EUR
−45.65 MEUR
319.82 KEUR
67.04 M
About aTyr Pharma, Inc.
Sector
CEO
Sanjay S. Shukla
Headquarters
San Diego
Website
Employees (FY)
59
Founded
2005
FIGI
BBG00CWZS189
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BER exchange ATYR PHARMA INC. DL -,001 stocks are traded under the ticker 471A.
We've gathered analysts' opinions on ATYR PHARMA INC. DL -,001 future price: according to them, 471A price has a max estimate of 32.40 EUR and a min estimate of 14.81 EUR. Watch 471A chart and read a more detailed ATYR PHARMA INC. DL -,001 stock forecast: see what analysts think of ATYR PHARMA INC. DL -,001 and suggest that you do with its stocks.
471A reached its all-time high on Sep 24, 2021 with the price of 10.700 EUR, and its all-time low was 1.000 EUR and was reached on Nov 16, 2023. View more price dynamics on 471A chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track ATYR PHARMA INC. DL -,001 financials in yearly and quarterly reports right on TradingView.
ATYR PHARMA INC. DL -,001 is going to release the next earnings report on Aug 14, 2024. Keep track of upcoming events with our Earnings Calendar.
471A earnings for the last quarter are −0.21 EUR per share, whereas the estimation was −0.23 EUR resulting in a 8.00% surprise. The estimated earnings for the next quarter are −0.22 EUR per share. See more details about ATYR PHARMA INC. DL -,001 earnings.
ATYR PHARMA INC. DL -,001 revenue for the last quarter amounts to 217.79 K EUR, despite the estimated figure of 33.98 K EUR. In the next quarter, revenue is expected to reach 28.03 K EUR.
471A net income for the last quarter is −14.36 M EUR, while the quarter before that showed −13.37 M EUR of net income which accounts for −7.36% change. Track more ATYR PHARMA INC. DL -,001 financial stats to get the full picture.
No, 471A doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 30, 2024, the company has 59.00 employees. See our rating of the largest employees — is ATYR PHARMA INC. DL -,001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ATYR PHARMA INC. DL -,001 EBITDA is −51.91 M EUR, and current EBITDA margin is −14.78 K%. See more stats in ATYR PHARMA INC. DL -,001 financial statements.
Like other stocks, 471A shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ATYR PHARMA INC. DL -,001 stock right from TradingView charts — choose your broker and connect to your account.